This is our experimental section. The data presented here is provisional and may be subject to more updates than other releases. We have developed ...

A new breed of veterinary clinic is changing how pets — and their owners — are treated. "I'd rather see four pets a day," one ...

BILL Holdings BILL has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from ...

Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, is announcing its financial results for the three and twelve months ended ...

Q4 2024 Earnings Call Transcript March 27, 2025 HireQuest, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.17. Operator: Greetings. Welcome to the HireQuest Inc. Fourth ...

Pilgrim's Pride shows strong growth potential with global chicken demand and automation support. Find out why PPC stock is a ...

FDA Approves EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyTotal Revenue $19 million, ...

The companion diagnostic (CDx) for EGFR exon 20 insertion mutation (exon20ins) for sunvozertinib, developed through the collaboration of Burning Rock and Dizal, has been approved by the National ...